Table 1.
Clinical, pathological, and functional characteristics of HGSOC patient‐derived samples. PFS, progression‐free survival. c/t, carboplatin/paclitaxel.
| PDX | Stage | Source | Chemotherapy | PFS (months) | |
|---|---|---|---|---|---|
|
14 | IVA | Ovary | 4 cycles c/t | No relapse |
| 5 | IVB | Ovary, cul‐de‐sac | No prior chemotherapy | 18 | |
| 9 | IIA | Omentum | 4 cycles c/t | 10 | |
| 1 | IVB | Ascites | No prior chemotherapy | 15 | |
| 3 | IVB | Ovary | 6 cycles c/t | 36 | |
| 8 | IIIC | Tumor | 6 cycles c/t | 7.5 | |
| 4 | IVB | Ovary, omentum | No prior chemotherapy | 16 | |
| 6 | IIIC | Ascites | No prior chemotherapy | No relapse |